E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/3/2008 in the Prospect News Special Situations Daily.

Datascope shareholders elect Loughlin, Dantzker to board of directors

By Lisa Kerner

Charlotte, N.C., Jan. 3 - Certified voting results from Datascope Corp.'s 2007 annual meeting show that shareholders re-elected James J. Loughlin and elected Dr. David Dantzker, a Ramius Capital Group, LLC nominee, to its board of directors.

Loughlin, chair of the audit committee since 2004, was named lead independent director at the meeting held on Dec. 20.

Dantzker is a general partner at Wheatley MedTech Partners, LP, it was previously reported.

Ramius' second nominee, William J. Fox, was not elected.

"On behalf of Datascope's board and management team, I thank all of our shareholders for their continued support and confidence throughout this proxy process," Datascope chairman and chief executive officer Lawrence Saper said in a company news release.

Datascope and Ramius were engaged in a public war of words over the past few months.

Ramius accused Datascope of trying to distort facts and mislead shareholders regarding the board's investigation into alleged ethics violations, while Saper said Ramius lacked any plan or vision that would benefit Datascope and its shareholders, according to prior news releases.

Datascope is a Montvale, N.J., medical device company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.